[adrotate group="2"]

BOOM! Parataxis Capital Set to Strike it BIG with $640 Million Merger!

BREAKING NEWS: Bitcoin is BACK and Bigger than Ever! Parataxis Capital is about to make waves as it skyrockets to public status with a sensational merger with SilverBox Corp IV! This jaw-dropping deal could rake in a whopping $640 MILLION!

$240 Million + $400 Million = $640 Million—Can You Feel the Excitement? This explosive merger combines massive trust capital with an incredible equity facility, launching Parataxis onto the New York Stock Exchange under the fiery ticker PRTX!

But wait, there’s more! This New York-based powerhouse specializes in smashing digital asset strategies and generating Bitcoin yield that will leave competitors gasping for air. Guess what? They’ve already locked in $31 MILLION for initial Bitcoin purchases before the ink has even dried on this deal!

The Countdown Begins! With regulatory approvals in play, they expect to wrap this blockbuster transaction by Q4 2025. Are you ready for the Bitcoin revolution?!

Why Is Everyone Racing to Go Public? It seems like the floodgates have swung wide open for companies scrambling to scoop up Bitcoin! The number of firms boasting BTC on their balance sheets has nearly DOUBLED this year, now surpassing a staggering 230 companies globally! What’s driving this meteoric rise? High-profile players like Strategy, Metaplanet, and Semler Scientific have made their mark, and Parataxis is ready to take the crown by capitalizing on active yield-generation and global exposure!

SPAC ATTACK! The financial world is in chaos over renewed enthusiasm for blank-check deals in the crypto arena! Earlier this year, ProCap’s $1 BILLION SPAC plan set the stage ablaze for digital asset giants eyeing the public market. Parataxis’s mega-merger with SilverBox may just be the biggest splash since 2021! This is not just about gathering Bitcoin; it’s about launching a juggernaut of institutional strategies!

AND THERE’S MORE! Parataxis isn’t stopping at borders—oh no! They’ve just completed a strategic move into South Korea with the ₩25 billion acquisition of Bridge Biotherapeutics. This screams opportunity, transforming the biotech firm into Parataxis Korea—a regional powerhouse targeting Bitcoin treasury ambitions in a market where traditional ETF investments are almost a pipe dream.

BAM! Since the takeover announcement, Bridge Biotherapeutics’s stock has skyrocketed a jaw-dropping 4.5 TIMES! Investors are buzzing about the incredible shift from biotech to Bitcoin in a landscape choked by regulatory red tape. South Korea’s legalized real-name crypto accounts for over 3,000 institutions mean listed BTC operations are set to THRIVE.

VISIONARY ALERT! Edward Chin, the fearless CEO of Parataxis, is ready to conquer the Bitcoin landscape—in his bold words, they’ll be “well-capitalized to execute a BTC treasury strategy in the US” while others look on enviously. SilverBox co-managing partner Joe Reece hails the venture as “unique and highly scalable,” addressing the critical demand for structured digital asset access in public markets!

Don’t Miss Out! The agreement with CF Principal Investments opens a treasure chest of optionality for capital drawdowns—we’re talking serious dollar signs here! While the structure could lower SPAC redemption risks, it also leaves some potential for future dilution—yikes!

Keep Your Eyes Peeled! With Form S-4 registration pending, the combined powerhouse is aiming for a Q4 listing under PRTX! Parataxis is on a crash course for expanding Bitcoin buys, both in the US and through its Korean subsidiary. They’re all set to bridge the gap between Western capital and Eastern demand stifled by regulation—are we witnessing the dawn of a new crypto era?

This transaction could propel Parataxis to the forefront, making it one of the most robust Bitcoin-native entities in the public market! Get Ready—The Future Looks BRIGHT for Bitcoin!